Hopp til innholdet
innsidehandel

← Alle transaksjoner

Thor Medical - Issuance of RSU shares to members of the board

Thor Medical ASA (TRMED) · publisert 11. november 2025 kl. 23:15 · vis på NewsWeb

Transaksjoner

PersonRolleTypeVolumPrisDatoISINHandelsplass
John Andersen via Scatec Innovation ASStyremedlemKjøp Tildeling344 5183,615 NOK11. november 2025NO0010597883Outside trading venue
John Andersen StyremedlemAnnet Tildeling344 5180,2 NOK11. november 2025NO0010597883Outside trading venue NOTIFICATION OF TRANSACTIONS PURSUANT TO THE MARKET ABUSE REGULATION ARTICLE 19
Mimi Kristine Berdal StyremedlemAnnet Tildeling344 5180,2 NOK11. november 2025NO0010597883Outside trading venue
John Andersen StyremedlemSalg Tildeling344 5183,615 NOK11. november 2025NO0010597883Outside trading venue NOTIFICATION OF TRANSACTIONS PURSUANT TO THE MARKET ABUSE REGULATION ARTICLE 19

Vedlegg

Meldingstekst

11.11.2025 23:15:10 CET | Thor Medical ASA | Mandatory notification of trade primary insiders Reference is made to the stock exchange announcement made by Thor Medical ASA, the "Company") on 21 April 2024 regarding grant of restricted share units ("RSU") to the members of the board. The Company's board of directors has today resolved to issue 1,090,974 new shares in the Company pursuant to the RSU-program. Current board members, John Andersen and Mimi Kristine Berdal, have each been issued 344,518 new shares. John Andersen has agreed to transfer all 344,518 shares to Scatec Innovation AS, where John Andersen is the CEO, a close associate of a primary insider of the Company. Notifications of the transaction in accordance with the Market Abuse Regulation Article 19 are attached with this announcement. CONTACTS * Brede Ellingsæter, CFOO, Thor Medical ASA, +47 472 38 440, brede.ellingseter@thormedical.com ABOUT THOR MEDICAL ASA Thor Medical is an emerging supplier of radionuclides, primarily alpha particle emitters, from naturally occurring thorium. Its proprietary production process requires no irradiation or use of nuclear reactors, and provides reliable, environmentally friendly, cost-efficient supply of alpha-emitters for the radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'. To learn more, visitwww.thormedical.com - https://www.thormedical.com. ATTACHMENTS Download announcement as PDF.pdf - https://kommunikasjon.ntb.no/ir-files/17848634/18716187/6556/Download%20announce ment%20as%20PDF.pdf 20251111 - TRMED - MAR forms RSU share issue 2025.pdf - https://kommunikasjon.ntb.no/ir-files/17848634/18716187/6554/20251111%20-%20TRME D%20-%20MAR%20forms%20RSU%20share%20issue%202025.pdf 20251111 - TRMED - MAR forms Scatec Innovations_John Andersen RSU share transfer.pdf - https://kommunikasjon.ntb.no/ir-files/17848634/18716187/6555/20251111%20-%20TRME D%20-%20MAR%20forms%20Scatec%20Innovations_John%20Andersen%20RSU%20share%20trans fer.pdf